A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study

Sara Gagno, Giuseppe Toffoli, Mauro Mansutti et al.|Clinical Breast Cancer|2018

Cited by 10